Back to User profile » Dr Chi-Chuan Wang
Papers published by Dr Chi-Chuan Wang:
Cardiovascular Risks of Aromatase Inhibitors versus Tamoxifen in Postmenopausal Breast Cancer: A Multinational Cohort Study
Hu SC, Gaber CE, Lo C, Su HN, Wang CC, Yeh CF, Hassan L, Pickard AS, Lee TA, Lin FJ
Clinical Epidemiology 2026, 18:547763
Published Date: 13 January 2026
Pharmacist-Led Intervention to Enhance Direct Oral Anticoagulant Adherence and Treatment Outcomes in Atrial Fibrillation: A Pragmatic Clinical Trial
Liu SY, Huang YM, Lin SY, Wang CC
Patient Preference and Adherence 2026, 20:565777
Published Date: 8 January 2026
Effect of SGLT2 Inhibitors on Diabetes Progression in Statin-Treated Patients: A Population-Based Cohort Study
Cheng JSC, Lin F, Fu CM, Lin S, Wang CY, Huang HY, Wang CC
Clinical Epidemiology 2025, 17:421-433
Published Date: 21 April 2025
Comparison of Bleeding Risk Between Colistin–Tigecycline and Colistin–Carbapenem Treatment Regimens: A Retrospective Cohort Study
Huang YT, Yu CI, Chen PY, Wang CC, Wu CC
Infection and Drug Resistance 2021, 14:4949-4955
Published Date: 25 November 2021
Augmented renal clearance is associated with inadequate antibiotic pharmacokinetic/pharmacodynamic target in Asian ICU population: a prospective observational study
Wu CC, Tai CH, Liao WY, Wang CC, Kuo CH, Lin SW, Ku SC
Infection and Drug Resistance 2019, 12:2531-2541
Published Date: 16 August 2019